Log in to save to my catalogue

Angelman syndrome patient neuron screen identifies a potent and selective clinical ASO targeting UBE...

Angelman syndrome patient neuron screen identifies a potent and selective clinical ASO targeting UBE...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2675432834

Angelman syndrome patient neuron screen identifies a potent and selective clinical ASO targeting UBE3A-ATS with long lasting effect in cynomolgus monkey

About this item

Full title

Angelman syndrome patient neuron screen identifies a potent and selective clinical ASO targeting UBE3A-ATS with long lasting effect in cynomolgus monkey

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2022-06

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by the loss of neuronal E3 ligase UBE3A with no available treatment. Restoring UBE3A levels via downregulation of the paternally cis-acting long non-coding antisense transcript (UBE3A-ATS) is a potentially disease modifying. Developing molecules targeting human UBE3A-ATS is chall...

Alternative Titles

Full title

Angelman syndrome patient neuron screen identifies a potent and selective clinical ASO targeting UBE3A-ATS with long lasting effect in cynomolgus monkey

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2675432834

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2675432834

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2022.06.09.495066